A patient-centric approach to optimise insulin therapy in Asia
J Diabetes Complications
.
2016 Aug;30(6):973-80.
doi: 10.1016/j.jdiacomp.2016.05.019.
Epub 2016 May 24.
Authors
Su Yen Goh
1
,
Ernesto Ang
2
,
Shailendra Bajpai
3
,
Chaicharn Deerochanawong
4
,
Eun-Gyoung Hong
5
,
Zanariah Hussein
6
,
Shashank Joshi
7
,
Nor Azmi Kamaruddin
8
,
Sjoberg Kho
9
,
Alice Pik-Shan Kong
10
,
Chang Yu Pan
11
,
Riccardo Perfetti
12
,
Apichati Vichayanrat
13
,
Aleksandra Vlajnic
12
,
Juliana Chung-Ngor Chan
14
Affiliations
1
Singapore General Hospital, Singapore.
2
Cardinal Santos Medical Center, San Juan, Philippines; The Institute for Studies on Diabetes Foundation Inc., Metro Manila, Philippines.
3
Sanofi, Singapore.
4
Rajavithi Hospital, Rangsit University, Bangkok, Thailand.
5
Hallym University School of Medicine, Dongtan Sacred Heart Hospital, Gyeonggi-do, South Korea.
6
Putrajaya Hospital, Putrajaya, Malaysia.
7
Lilavati Hospital, Mumbai, India.
8
Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur.
9
University of Santo Tomas, Manila, Philippines.
10
The Chinese University of Hong Kong, Hong Kong, China.
11
Chinese PLA General Hospital, Beijing, China.
12
Sanofi, USA.
13
Siriraj Hospital, Bangkok, Thailand.
14
The Chinese University of Hong Kong, Hong Kong, China. Electronic address: jchan@cuhk.edu.hk.
PMID:
27288201
DOI:
10.1016/j.jdiacomp.2016.05.019
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Asia
Diabetes Mellitus / drug therapy*
Humans
Insulin / therapeutic use*
Patient-Centered Care*
Substances
Insulin